Recent technological advances uncovered intricate biological processes underlying intratumor heterogeneity with clinical implications. These insights led to novel biomarkers for immunotherapies, justified serial tumour biopsies for therapeutic target profiling, inspired new treatment strategies, and ultimately might yield novel therapeutics that target clonal interdependence.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938204 | PMC |
http://dx.doi.org/10.1038/s41416-022-02008-w | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!